<p>Disclosed is an agent for preventing the occurrence and/or progression of cancer in a patient who has hyperinsulinism or is at risk of hyperinsulinism by inhibiting the activation of Akt An Akt activation inhibitor comprising at least one branched amino acid selected from isoleucine, leucine and valine as an active ingredient.</p>
